Ad Lobbies Tackle FDA On Proposed Bill

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Advertising lobby groups stepped up pressure last week to halt the progress of a bipartisan bill with sweeping cigarette-advertising restrictions.
The bill, sponsored by Reps. Greg Ganske, R-Iowa; John Dingell, D-Mich.; and Henry Waxman, D-Calif., lets the U.S. Food and Drug Administration regulate tobacco. Under FDA rules, written in 1996 and challenged by the tobacco industry, cigarette ads would be limited to black-and-white “tombstone” formats; outdoor ads near schools or playgrounds would be banned. Ads could only be in publications with fewer than 2 million readers under 18, along with health warnings.
“When Joe Camel is associated with cigarettes by 30 percent of 3-year-olds and nearly 90 percent of 5-year-olds, we know that marketing efforts directed at children are very successful,” Ganske said.
The Freedom to Advertise Coalition, representing the American Association of Advertising Agencies and other groups, sent a letter to a key House subcommittee to stop the bill from becoming an...


AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in